Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Oncolytic MG1-MAGEA3 With Ad-MAGEA3 Vaccine in Combination With Pembrolizumab for Non-Small Cell Lung Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02879760
Recruitment Status : Completed
First Posted : August 26, 2016
Last Update Posted : October 6, 2020
Sponsor:
Information provided by (Responsible Party):
Turnstone Biologics, Corp.